How to buy Sio Gene Therapies stock - 20 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Sio Gene Therapies stock

Own Sio Gene Therapies stock in just a few minutes.

Sio Gene Therapies, Inc is a biotechnology business based in the US. Sio Gene Therapies shares (SIOX) are listed on the NASDAQ and all prices are listed in US Dollars. Sio Gene Therapies employs 38 staff and has a market cap (total outstanding shares value) of USD0.00.

How to buy shares in Sio Gene Therapies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Sio Gene Therapies. Find the stock by name or ticker symbol: SIOX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Sio Gene Therapies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Sio Gene Therapies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Sio Gene Therapies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Sio Gene Therapies share price

Use our graph to track the performance of SIOX stocks over time.

Sio Gene Therapies shares at a glance

Information last updated 2021-04-14.
52-week rangeUSD$1.87 - USD$5.74
50-day moving average USD$2.65
200-day moving average USD$2.90
Wall St. target priceUSD$8.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Sio Gene Therapies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sio Gene Therapies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sio Gene Therapies financials

Gross profit TTM USD$0
Return on assets TTM -40.75%
Return on equity TTM -97.25%
Profit margin 0%
Book value N/A
Market capitalisation USD$149.2 million

TTM: trailing 12 months

Shorting Sio Gene Therapies shares

There are currently 759,147 Sio Gene Therapies shares held short by investors – that's known as Sio Gene Therapies's "short interest". This figure is 49.2% up from 508,708 last month.

There are a few different ways that this level of interest in shorting Sio Gene Therapies shares can be evaluated.

Sio Gene Therapies's "short interest ratio" (SIR)

Sio Gene Therapies's "short interest ratio" (SIR) is the quantity of Sio Gene Therapies shares currently shorted divided by the average quantity of Sio Gene Therapies shares traded daily (recently around 1.4 million). Sio Gene Therapies's SIR currently stands at 0.54. In other words for every 100,000 Sio Gene Therapies shares traded daily on the market, roughly 540 shares are currently held short.

However Sio Gene Therapies's short interest can also be evaluated against the total number of Sio Gene Therapies shares, or, against the total number of tradable Sio Gene Therapies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sio Gene Therapies's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Sio Gene Therapies shares in existence, roughly 10 shares are currently held short) or 0.019% of the tradable shares (for every 100,000 tradable Sio Gene Therapies shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sio Gene Therapies.

Find out more about how you can short Sio Gene Therapies stock.

Sio Gene Therapies share dividends

We're not expecting Sio Gene Therapies to pay a dividend over the next 12 months.

Sio Gene Therapies share price volatility

Over the last 12 months, Sio Gene Therapies's shares have ranged in value from as little as $1.87 up to $5.74. A popular way to gauge a stock's volatility is its "beta".

SIOX.US volatility(beta: 1.71)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sio Gene Therapies's is 1.7126. This would suggest that Sio Gene Therapies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Sio Gene Therapies overview

Sio Gene Therapies, Inc. , a clinical-stage gene therapy company, focuses on developing various product candidates for debilitating neurodegenerative diseases. The company's clinical-stage programs include AXO-Lenti-PD program for the treatment of Parkinson's disease; AXO-AAV-GM1 program for the treatment of GM1 gangliosidosis; and AXO-AAV-GM2 program for the treatment of GM2 gangliosidosis. It has a license agreement with Oxford BioMedica (UK) Ltd. and The University of Massachusetts Medical School. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site